Swedish study reports low vision loss risk with GLP-1RAs
1. In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ischemic ...
Tag: dpp4i
Risk of major adverse cardiovascular events is lowest with glucagon-like-peptide-1 receptor agonists among patients with type 2 diabetes being treated with antihyperglycemics
1. In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...
